Roberto Lara

6 Followers

As Director of Business Development my mission is to attract novel oncology compounds/trials to Canada, and ensure the delivery of tailored Oncology Drug Development solutions throughout North America. Since 2008, I have been involved in conceptualizing and leading Scimega's Reverse Feasibility Program - a novel CRO approach to site selection & patient recruitment - that accelerates study start-up by matching sponsor protocols with the 'real-time' needs of Canada's top oncologists and their patients. I am responsible for developing, launching and executing strategic sales, brand alignment, as well as, inbound marketing campaigns, including: sales tools, product messaging, direct mail, ...

cancer clinical operations oncology oncology clinical trials clinical oncology patient recruitment clinical research clinical monitoring feasibility study cro internal review boards scimega research pre-qualification visit irb scimega project management canada reverse feasibility site selection study start up oncology investigators pre-qualification visits clinical trial application first-patient in study expansion site enrichment clinical trials personalized medicine investigational new drug application cta

Activity
About

Roberto Lara

Presentations

Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials

Solving the operational challenges of oncology clinical trials

What Your CRO Doesn't Know Could Hurt You

AACR Cancer Progress Report 2015

The Secret to Successful Early Phase Study Expansions in Canada

Documents

Canadian CTA vs. U.S. IND

The Reverse Feasibility Program

Oncology Clinical Development Challenges and Opportunities in the Phase 1 Setting

Likes

What Your CRO Doesn't Know Could Hurt You